RHOA and cancer: In breast cancer targeted anti-cancer therapy, several key genes are targeted such as CTNND1, CDC42 and DVL. Over expression of P120-CATENIN tremendously inhibited several signaling molecules such as RHOA, RAC1 and CDC42 which are involved in the regulation of numerous cellular functions [100].